-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Collegium Pharmaceutical, Inc quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q2 2016 to Q1 2025.
- Collegium Pharmaceutical, Inc Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending March 31, 2025 was $229M, a 30.9% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)